Benazzi Franco
E Hecker Outpatient Psychiatry Center, Ravenna, Italy.
Int J Methods Psychiatr Res. 2005;14(2):82-91. doi: 10.1002/mpr.19.
The evidence supporting the DSM-IV definition of atypical depression (AD) is weak. This study aimed to test different definitions of AD. Major depressive disorder (MDD) patients (N = 254) and bipolar-II (BP-II) outpatients (N = 348) were interviewed consecutively, during major depressive episodes, with the Structured Clinical Interview for DSM-IV. DSM-IV criteria for AD were followed. AD validators were female gender, young onset, BP-II, axis I comorbidity, bipolar family history. Frequency of DSM-IV AD was 43.0%. AD, versus non-AD, was significantly associated with all AD validators, apart from comorbidity when controlling for age and sex. Factor analysis of atypical symptoms found factor 1 including oversleeping, overeating and weight gain (leaden paralysis at trend correlation), and factor 2 including interpersonal sensitivity, mood reactivity, and leaden paralysis. Multiple logistic regression of factor 1 versus AD validators found significant associations with several validators (including bipolar family history), whereas factor 2 had no significant associations. Findings may support a new definition of AD based on the state-dependent features oversleeping and overeating (plus perhaps leaden paralysis) versus the current AD definition based on a combination of state and trait features. Pharmacological studies are required to support any new definition of AD, as the current concept of AD is based on different response to TCA antidepressants versus non-AD.
支持《精神疾病诊断与统计手册》第四版(DSM-IV)对非典型抑郁症(AD)定义的证据并不充分。本研究旨在检验AD的不同定义。在重度抑郁发作期间,对254名重度抑郁症(MDD)患者和348名双相II型障碍(BP-II)门诊患者连续进行了DSM-IV结构化临床访谈。遵循DSM-IV的AD标准。AD的验证指标包括女性、起病年龄小、BP-II、轴I共病、双相家族史。DSM-IV中AD的发生率为43.0%。除了在控制年龄和性别时的共病情况外,AD与所有AD验证指标均显著相关。对非典型症状进行因子分析发现,因子1包括嗜睡、暴饮暴食和体重增加(铅样麻痹呈趋势相关),因子2包括人际敏感性、情绪反应性和铅样麻痹。因子1与AD验证指标的多元逻辑回归分析发现,因子1与几个验证指标(包括双相家族史)存在显著关联,而因子2则无显著关联。研究结果可能支持基于状态依赖特征嗜睡和暴饮暴食(可能还包括铅样麻痹)对AD进行新的定义,而目前AD的定义是基于状态和特质特征的组合。由于目前AD的概念是基于对三环类抗抑郁药与非AD的不同反应,因此需要进行药理学研究以支持AD的任何新定义。